83 FR 44277 - Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2019
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 83, Issue 169 (August 30, 2018)
Food and Drug Administration
Federal Register Volume 83, Issue 169 (August 30, 2018)
| Page Range | 44277-44280 | |
| FR Document | 2018-18802 |
[Federal Register Volume 83, Number 169 (Thursday, August 30, 2018)] [Notices] [Pages 44277-44280] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-18802] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-4119] Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2019 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing the fiscal year (FY) 2019 annual fee rate for recognized accreditation bodies and accredited certification bodies, and the fee rate for accreditation bodies applying to be recognized in the third-party certification program that is authorized by the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the FDA Food Safety Modernization Act (FSMA). We are also announcing the fee rate for certification bodies that are applying to be directly accredited by FDA. DATES: This fee is effective October 1, 2018. FOR FURTHER INFORMATION CONTACT: Donald Prater, Office of Foods and Veterinary Medicine, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 3234, Silver Spring, MD 20993, 301-348-3007. SUPPLEMENTARY INFORMATION: I. Background Section 307 of FSMA, Accreditation of Third-Party Auditors, amended the FD&C Act to create a new provision, section 808, under the same name. Section 808 of the FD&C Act (21 U.S.C. 384d) directs FDA to establish a program for accreditation of third-party certification bodies \1\ conducting food safety audits and issuing food and facility certifications to eligible foreign entities (including registered foreign food facilities) that meet our applicable requirements. Under this provision, we established a system for FDA to recognize accreditation bodies to accredit certification bodies, except for limited circumstances in which we may directly accredit certification bodies to participate in the third-party certification program. --------------------------------------------------------------------------- \1\ For the reasons explained in the third-party certification final rule (80 FR 74570 at 74578-74579, November 27, 2015), and for consistency with the implementing regulations for the third-party certification program in 21 CFR parts 1, 11, and 16, this notice uses the term ``third-party certification body'' rather than the term ``third-party auditor'' used in section 808(a)(3) of the FD&C Act. --------------------------------------------------------------------------- Section 808(c)(8) of the FD&C Act directs FDA to establish a reimbursement (user fee) program by which we assess fees and require reimbursement for the work FDA performs to establish and administer the third-party certification program under section 808 of the FD&C Act. The user fee program for the third-party certification program was established by a final rule entitled ``Amendments to Accreditation of Third-Party Certification Bodies To Conduct Food Safety Audits and To Issue Certifications To Provide for the User Fee Program'' (81 FR 90186, December 14, 2016). The FSMA FY 2019 third-party certification program user fee rate announced in this notice is effective on October 1, 2018, and will remain in effect through September 30, 2019. II. Estimating the Average Cost of a Supported Direct FDA Work Hour for FY 2019 In each year, the costs of salary (or personnel compensation) and benefits [[Page 44278]] for FDA employees account for between 50 and 60 percent of the funds available to, and used by, FDA. Almost all of the remaining funds (operating funds) available to FDA are used to support FDA employees for paying rent, travel, utility, information technology, and other operating costs. A. Estimating the Full Cost per Direct Work Hour in FY 2019 Full-time Equivalent (FTE) reflects the total number of regular straight-time hours--not including overtime or holiday hours--worked by employees, divided by the number of compensable hours applicable to each fiscal year. Annual leave, sick leave, compensatory time off, and other approved leave categories are considered ``hours worked'' for purposes of defining FTE employment. In general, the starting point for estimating the full cost per direct work hour is to estimate the cost of an FTE or paid staff year. Calculating an Agency-wide total cost per FTE requires three primary cost elements: Payroll, non-payroll, and rent. We have used an average of past year cost elements to predict the FY 2019 cost. The FY 2019 FDA-wide average cost for payroll (salaries and benefits) is $157,731; non-payroll--including equipment, supplies, information technology, general and administrative overhead--is $91,008; and rent, including cost allocation analysis and adjustments for other rent and rent-related costs, is $24,400 per paid staff year, excluding travel costs. Summing the average cost of an FTE for payroll, non-payroll, and rent, brings the FY 2019 average fully supported cost to $273,139 per FTE, excluding travel costs. FDA will use this base unit fee in determining the hourly fee rate for third-party certification user fees for FY 2019 prior to including travel costs as applicable for the activity. To calculate an hourly rate, FDA must divide the FY 2019 average fully supported cost of $273,139 per FTE by the average number of supported direct FDA work hours in FY 2017--the last FY for which data are available. See table 1. Table 1--Supported Direct FDA Work Hours in a Paid Staff Year in FY 2017 ------------------------------------------------------------------------ ------------------------------------------------------------------------ Total number of hours in a paid staff year................. 2,080 Less: 10 paid holidays......................................... -80 20 days of annual leave.................................. -160 10 days of sick leave.................................... -80 12.5 days of training.................................... -100 26.5 days of general administration...................... -184 26.5 days of travel...................................... -212 2 hours of meetings per week............................. -104 ------------ Net Supported Direct FDA Work Hours Available for = 1,160 Assignments........................................... ------------------------------------------------------------------------ Dividing the average fully supported FTE cost in FY 2019 ($273,139) by the total number of supported direct work hours available for assignment in FY 2017 (1,160) results in an average fully supported cost of $235 (rounded to the nearest dollar), excluding travel costs, per supported direct work hour in FY 2019. B. Adjusting FY 2017 Travel Costs for Inflation To Estimate FY 2019 Travel Costs To adjust the hourly rate for FY 2019, FDA must estimate the cost of inflation in each year for FY 2018 and FY 2019. FDA uses the method prescribed for estimating inflationary costs under the Prescription Drug User Fee Act (PDUFA) provisions of the FD&C Act (section 736(c)(1) (21 U.S.C. 379h(c)(1)), the statutory method for inflation adjustment in the FD&C Act that FDA has used consistently. FDA previously determined the FY 2018 inflation rate to be 1.6868 percent; this rate was published in the FY 2018 PDUFA user fee rates notice in the Federal Register (82 FR 43244, September 14, 2017). Utilizing the method set forth in section 736(c)(1) of the FD&C Act, FDA has calculated an inflation rate of 1.6868 percent for FY 2018 and 1.7708 percent for FY 2019, and FDA intends to use this inflation rate to make inflation adjustments for FY 2019 for several of its user fee programs; the derivation of this rate is published in the Federal Register in the FY 2019 notice for the PDUFA user fee rates (83 FR 37504 at 37505, August 1, 2018). The compounded inflation rate for FYs 2018 and 2019, therefore, is 1.034875 (or 3.4875 percent) (1 plus 1.6868 percent times 1 plus 1.7708 percent). The average fully supported cost per supported direct FDA work hour, excluding travel costs, of $235 already takes into account inflation as the calculation above is based on FY 2019 predicted costs. FDA will use this base unit fee in determining the hourly fee rate for third-party certification program fees for FY 2019 prior to including travel costs as applicable for the activity. For the purpose of estimating the fee, we are using the travel cost rate for foreign travel because we anticipate that the vast majority of onsite assessments made by FDA under this program will require foreign travel. In FY 2017, the Office of Regulatory Affairs spent a total of $2,566,050 on 480 foreign inspection trips related to FDA's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine field activities programs, which averaged a total of $5,346 per foreign inspection trip. These trips averaged 3 weeks (or 120 paid hours) per trip. Dividing $5,346 per trip by 120 hours per trip results in a total and an additional cost of $45 (rounded to the nearest dollar) per paid hour spent for foreign inspection travel costs in FY 2017. To adjust $45 for inflationary increases in FY 2018 and FY 2019, FDA must multiply it by the same inflation factor mentioned previously in this document (1.034875 or 3.4875 percent), which results in an estimated cost of $47 (rounded to the nearest dollar) per paid hour in addition to $235 for a total of $282 per paid hour ($235 plus $47) for each direct hour of work requiring foreign inspection travel. FDA will use these rates in charging fees in FY 2019 when travel is required for the third-party certification program. Table 2--FSMA Fee Schedule for FY 2019 ------------------------------------------------------------------------ Fee rates Fee category for FY 2019 ------------------------------------------------------------------------ Hourly rate without travel................................. $235 Hourly rate if travel is required.......................... 282 ------------------------------------------------------------------------ III. Fees for Accreditation Bodies and Certification Bodies in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act The third-party certification program assesses application fees and annual fees. In FY 2019, the only fees that could be collected by FDA under section 808(c)(8) of the FD&C Act are the initial application fee for accreditation bodies seeking recognition, the annual fee for recognized accreditation bodies, the annual fee for certification bodies accredited by a recognized accreditation body, and the initial application fee for a certification body seeking direct accreditation from FDA. Table 3 provides an overview of the fees for FY 2019. [[Page 44279]] Table 3--FSMA Third-Party Certification Program User Fee Schedule for FY 2019 ------------------------------------------------------------------------ Fee rates Fee category for FY 2019 ------------------------------------------------------------------------ Initial Application Fee for Accreditation Body Seeking $38,211 Recognition............................................... Annual Fee for Recognized Accreditation Body............... 1,775 Annual Fee for Accredited Certification Body............... 2,219 Initial Application Fee for a Certification Body Seeking 38,211 Direct Accreditation from FDA............................. ------------------------------------------------------------------------ A. Application Fee for Accreditation Bodies Applying for Recognition in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act Section 1.705(a)(1) (21 CFR 1.705(a)(1)) establishes an application fee for accreditation bodies applying for initial recognition that represents the estimated average cost of the work FDA performs in reviewing and evaluating initial applications for recognition of accreditation bodies. The fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. These estimates represent FDA's current thinking, and as the program evolves, FDA will reconsider the estimated hours. We estimate that it would take, on average, 60 person-hours to review an accreditation body's submitted application, 48 person-hours for an onsite performance evaluation of the applicant (including travel and other steps necessary for a fully supported FTE to complete an onsite assessment), and 45 person-hours to prepare a written report documenting the onsite assessment. FDA employees are likely to review applications and prepare reports from their worksites, so we use the fully supported FTE hourly rate excluding travel, $235/hour, to calculate the portion of the user fee attributable to those activities: $235/hour x (60 hours + 45 hours) = $24,675. FDA employees will likely travel to foreign countries for the onsite performance evaluations because most accreditation bodies are anticipated to be located in foreign countries. For this portion of the fee we use the fully supported FTE hourly rate for work requiring travel, $282/hour, to calculate the portion of the user fee attributable to those activities: $282/hour x 48 hours (i.e., two fully supported FTEs x ((2 travel days x 8 hours) + (1 day onsite x 8 hours))) = $13,536. The estimated average cost of the work FDA performs in total for reviewing an initial application for recognition for an accreditation body based on these figures would be $24,675 + $13,536 = $38,211. Therefore, the application fee for accreditation bodies applying for recognition in FY 2019 will be $38,211. B. Annual Fee for Accreditation Bodies Participating in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act To calculate the annual fee for each recognized accreditation body, FDA takes the estimated average cost of work FDA performs to monitor performance of a single recognized accreditation body and annualizes that over the average term of recognition. At this time we assume an average term of recognition of 5 years. We also assume that FDA will monitor 10 percent of recognized accreditation bodies onsite. As the program proceeds, we will adjust the term of recognition as appropriate. We estimate that for one performance evaluation of a recognized accreditation body, it would take, on average (taking into account that not all recognized accreditation bodies would be monitored onsite), 24 hours for FDA to conduct records review, 8 hours to prepare a report detailing the records review and onsite performance evaluation, and 4.8 hours of onsite performance evaluation (i.e., 10 percent x two fully supported FTEs x ((2 travel days x 8 hours)) + (1 day onsite x 8 hours))). Using the fully supported FTE hourly rates in table 2, the estimated average cost of the work FDA performs to monitor performance of a single recognized accreditation body would be $7,520 ($235/hour x (24 hours + 8 hours)) plus $1,354 ($282/hour x 4.8 hours), which is $8,874. Annualizing this amount over 5 years would lead to an annual fee for recognized accreditation bodies of $1,775 for FY 2019. C. Annual Fee for Certification Bodies Accredited by a Recognized Accreditation Body in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act To calculate the annual fee for a certification body accredited by a recognized accreditation body, FDA takes the estimated average cost of work FDA performs to monitor performance of a single certification body accredited by a recognized accreditation body and annualizes that over the average term of accreditation. At this time we assume an average term of accreditation of 4 years. This fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. We estimate that FDA would conduct, on average, the same activities, for the same amount of time to monitor certification bodies accredited by a recognized accreditation body as we would to monitor an accreditation body recognized by FDA. Using the fully supported FTE hourly rates in table 2, the estimated average cost of the work FDA performs to monitor performance of a single accredited certification body would be $7,520 ($235/hour x (24 hours + 8 hours)) plus $1,354 ($282/hour x 4.8 hours), which is $8,874. Annualizing this amount over 4 years would lead to an annual fee for accredited certification bodies of $2,219 for FY 2019. D. Initial Application Fee for Certification Bodies Seeking Direct Accreditation From FDA in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act Section 1.705(a)(3) establishes an application fee for certification bodies applying for direct accreditation from FDA that represents the estimated average cost of the work FDA performs in reviewing and evaluating initial applications for direct accreditation of certification bodies. The fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. These estimates represent FDA's current thinking, and as the program evolves, FDA will reconsider the estimated hours. We estimate that it would take, on average, 60 person-hours to review a certification body's submitted application, 48 person-hours for an onsite performance evaluation of the applicant (including travel and other steps necessary for a fully supported FTE to complete an onsite assessment), and 45 person-hours to prepare a written report documenting the onsite assessment. FDA employees are likely to review applications and prepare reports from their worksites, so we use the fully supported FTE hourly rate excluding travel, $235/hour, to calculate the portion of the user fee attributable to those activities: $235/hour x (60 hours + 45 hours) = $24,675. FDA employees will likely travel to foreign countries for the onsite performance evaluations because most certification bodies are anticipated to be located in foreign countries. For this portion of the fee we use the fully supported FTE hourly rate for work requiring travel, $282/hour, to calculate the portion of the user fee attributable to those activities: $282/ [[Page 44280]] hour x 48 hours (i.e., two fully supported FTEs x ((2 travel days x 8 hours) + (1 day onsite x 8 hours))) = $13,536. The estimated average cost of the work FDA performs in total for reviewing an initial application for direct accreditation of a certification body based on these figures would be $24,675 + $13,536 = $38,211. Therefore, the application fee for certification bodies applying for direct accreditation from FDA in FY 2019 will be $38,211. IV. Estimated Fees for Accreditation Bodies and Certification Bodies in Other Fee Categories for FY 2019 Section 1.705(a) also establishes application fees for recognized accreditation bodies submitting renewal applications and certification bodies applying for renewal of direct accreditation. Section 1.705(b) also establishes annual fees for certification bodies directly accredited by FDA. Although we will not be collecting these other fees in FY 2019, for transparency and planning purposes, we have provided an estimate of what these fees would be for FY 2019 based on the fully supported FTE hourly rates for FY 2019 and estimates of the number of hours it would take FDA to perform relevant activities as outlined in the Final Regulatory Impact Analysis for the Third-Party Certification Regulation. Table 4 provides an overview of the estimated fees for other fee categories. Table 4--Estimated Fee Rates for Other Fee Categories Under the FSMA Third-Party Certification Program ------------------------------------------------------------------------ Estimated fee rates Fee category for FY 2019 ------------------------------------------------------------------------ Renewal application fee for recognized accreditation body.. $21,350 Renewal application fee for directly accredited 28,999 certification body........................................ Annual fee for certification body directly accredited by 21,056 FDA....................................................... ------------------------------------------------------------------------ V. How must the fee be paid? Accreditation bodies seeking initial recognition must submit the application fee with the application. For recognized accreditation bodies and accredited certification bodies, an invoice will be sent annually. Payment must be made within 30 days of the invoice date. Detailed payment information will be included with the invoice when it is issued. VI. What are the consequences of not paying this fee? The consequences of not paying these fees are outlined in 21 CFR 1.725. If FDA does not receive an application fee with an application for recognition, the application will be considered incomplete and FDA will not review the application. If a recognized accreditation body fails to submit its annual user fee within 30 days of the due date, we will suspend its recognition. If the recognized accreditation body fails to submit its annual user fee within 90 days of the due date, we will revoke its recognition. If an accredited certification body fails to pay its annual fee within 30 days of the due date, we will suspend its accreditation. If the accredited certification body fails to pay its annual fee within 90 days of the due date, we will withdraw its accreditation. Dated: August 24, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018-18802 Filed 8-29-18; 8:45 am] BILLING CODE 4164-01-P
![Federal Register / Vol. 83, No. 169 / Thursday, August 30, 2018 / Notices 44277
3. Updated background section that characteristics including any adaptive bodies that are applying to be directly
includes a brief history of the elements (e.g., decision criteria to add/ accredited by FDA.
development program and the status of drop a dose, etc.), and, if a Bayesian DATES: This fee is effective October 1,
product development and clinical data approach, how Bayesian methods are 2018.
to date, if applicable. being used for design and/or analysis FOR FURTHER INFORMATION CONTACT:
4. Proposed agenda, including purposes. Donald Prater, Office of Foods and
estimated times needed for discussion It is important that sponsors wishing Veterinary Medicine, Food and Drug
of each agenda item. to participate in the pilot program
5. List of questions for discussion Administration, 10903 New Hampshire
identify aspects of the design and Ave., Bldg. 1, Rm. 3234, Silver Spring,
with a brief summary of each question analysis that they consider non-
that explains the need or context for the MD 20993, 301–348–3007.
disclosable and provide a rationale for
question. SUPPLEMENTARY INFORMATION:
withholding the information.
6. Updated programs/shells for Participation in the pilot program, I. Background
simulations, if applicable. including any agreement on information
7. Summary of new information that Section 307 of FSMA, Accreditation
disclosure, will be voluntary and at the of Third-Party Auditors, amended the
is available to support discussions. discretion of the sponsor. Sponsors that FD&C Act to create a new provision,
E. Meeting Summaries do not wish to make such disclosures section 808, under the same name.
A meeting summary will be sent to may seek regulatory input through other Section 808 of the FD&C Act (21 U.S.C.
the sponsor within 60 days of each existing channels. 384d) directs FDA to establish a
meeting. IV. Paperwork Reduction Act of 1995 program for accreditation of third-party
certification bodies 1 conducting food
F. Disclosure This notice refers to collections of safety audits and issuing food and
To promote innovation and to provide information that are subject to review by facility certifications to eligible foreign
better clarity on the acceptance of the Office of Management and Budget entities (including registered foreign
different types of trial designs, trial (OMB) under the Paperwork Reduction food facilities) that meet our applicable
designs developed through the pilot Act of 1995 (44 U.S.C. 3501–3520). The requirements. Under this provision, we
program may be presented by FDA (e.g., collection of information resulting from established a system for FDA to
in a guidance or public workshop) as formal meetings between sponsors or recognize accreditation bodies to
case studies, including while the drug applicants and FDA has been approved accredit certification bodies, except for
studied in the trial has not yet been under OMB control number 0910–0429. limited circumstances in which we may
approved by FDA. Accordingly, before The collection of information in 21 CFR directly accredit certification bodies to
FDA grants the initial meeting under part 312 (investigational new drug participate in the third-party
this pilot program, FDA and the sponsor applications) has been approved under certification program.
must agree on the information that FDA OMB control number 0910–0014. Section 808(c)(8) of the FD&C Act
may include in these public case Dated: August 24, 2018. directs FDA to establish a
studies. The specific information to be Leslie Kux, reimbursement (user fee) program by
disclosed will depend on the content of Associate Commissioner for Policy.
which we assess fees and require
each application, but FDA intends to reimbursement for the work FDA
[FR Doc. 2018–18801 Filed 8–29–18; 8:45 am]
focus on information that is beneficial to performs to establish and administer the
BILLING CODE 4164–01–P
advancing the use of CIDs, and those third-party certification program under
elements relevant to the understanding section 808 of the FD&C Act. The user
of the CID and its potential use in a fee program for the third-party
DEPARTMENT OF HEALTH AND
clinical trial intended to support certification program was established by
HUMAN SERVICES
regulatory approval. Generally, the a final rule entitled ‘‘Amendments to
Agency does not anticipate that the case Food and Drug Administration Accreditation of Third-Party
studies will need to include information Certification Bodies To Conduct Food
such as molecular structure, the [Docket No. FDA–2016–N–4119] Safety Audits and To Issue
sponsor’s name, product name, subject- Certifications To Provide for the User
Food Safety Modernization Act Third- Fee Program’’ (81 FR 90186, December
level data, recruitment strategies,
Party Certification Program User Fee 14, 2016).
adverse events, or a complete
Rate for Fiscal Year 2019 The FSMA FY 2019 third-party
description of study eligibility criteria.
FDA does anticipate that the following AGENCY: Food and Drug Administration, certification program user fee rate
information will generally need to be HHS. announced in this notice is effective on
disclosed to facilitate discussion of the October 1, 2018, and will remain in
ACTION: Notice. effect through September 30, 2019.
proposed CID: Study endpoints to the
degree necessary to describe the design SUMMARY: The Food and Drug II. Estimating the Average Cost of a
(e.g., overall survival in the context of Administration (FDA) is announcing the Supported Direct FDA Work Hour for
a time to event analysis), target fiscal year (FY) 2019 annual fee rate for FY 2019
population, sample size and power recognized accreditation bodies and In each year, the costs of salary (or
determination, null and alternative accredited certification bodies, and the personnel compensation) and benefits
hypotheses, key operating fee rate for accreditation bodies
amozie on DSK3GDR082PROD with NOTICES1
characteristics, assumed rates for applying to be recognized in the third- 1 For the reasons explained in the third-party
dichotomous outcomes or mean and party certification program that is certification final rule (80 FR 74570 at 74578–
variance for continuous outcomes, authorized by the Federal Food, Drug, 74579, November 27, 2015), and for consistency
simulation objectives, simulation and Cosmetic Act (FD&C Act), as with the implementing regulations for the third-
party certification program in 21 CFR parts 1, 11,
scenarios, assumptions (e.g., dropout amended by the FDA Food Safety and 16, this notice uses the term ‘‘third-party
rate, rate of enrollment), modeling Modernization Act (FSMA). We are also certification body’’ rather than the term ‘‘third-party
characteristics, critical study design announcing the fee rate for certification auditor’’ used in section 808(a)(3) of the FD&C Act.
VerDate Sep<11>2014 17:25 Aug 29, 2018 Jkt 244001 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\30AUN1.SGM 30AUN1](https://thefederalregister.org/doc/83_FR_44446/page/1.svg)
![44280 Federal Register / Vol. 83, No. 169 / Thursday, August 30, 2018 / Notices
hour × 48 hours (i.e., two fully VI. What are the consequences of not of Biomedical Imaging and Bioengineering,
supported FTEs × ((2 travel days × 8 paying this fee? National Institutes of Health, 6707
hours) + (1 day onsite × 8 hours))) = Democracy Blvd., Suite 957, Bethesda, MD
The consequences of not paying these 20892, 301–496–4773, zhour@mail@nih.gov.
$13,536. The estimated average cost of fees are outlined in 21 CFR 1.725. If
the work FDA performs in total for Dated: August 23, 2018.
FDA does not receive an application fee
reviewing an initial application for with an application for recognition, the David D. Clary,
direct accreditation of a certification application will be considered Program Analyst, Office of Federal Advisory
body based on these figures would be incomplete and FDA will not review the Committee Policy.
$24,675 + $13,536 = $38,211. Therefore, application. If a recognized [FR Doc. 2018–18769 Filed 8–29–18; 8:45 am]
the application fee for certification accreditation body fails to submit its BILLING CODE 4140–01–P
bodies applying for direct accreditation annual user fee within 30 days of the
from FDA in FY 2019 will be $38,211. due date, we will suspend its
recognition. If the recognized DEPARTMENT OF HEALTH AND
IV. Estimated Fees for Accreditation HUMAN SERVICES
accreditation body fails to submit its
Bodies and Certification Bodies in
annual user fee within 90 days of the National Institutes of Health
Other Fee Categories for FY 2019
due date, we will revoke its recognition.
Section 1.705(a) also establishes If an accredited certification body fails National Toxicology Program Board of
application fees for recognized to pay its annual fee within 30 days of Scientific Counselors; Announcement
accreditation bodies submitting renewal the due date, we will suspend its of Meeting; Request for Comments
applications and certification bodies accreditation. If the accredited
certification body fails to pay its annual AGENCY: National Institutes of Health,
applying for renewal of direct HHS.
accreditation. Section 1.705(b) also fee within 90 days of the due date, we
will withdraw its accreditation. ACTION: Notice.
establishes annual fees for certification
bodies directly accredited by FDA. Dated: August 24, 2018. SUMMARY: This notice announces the
Although we will not be collecting Leslie Kux, next meeting of the National Toxicology
these other fees in FY 2019, for Associate Commissioner for Policy. Program (NTP) Board of Scientific
transparency and planning purposes, we [FR Doc. 2018–18802 Filed 8–29–18; 8:45 am] Counselors (BSC). The BSC, a federally
have provided an estimate of what these BILLING CODE 4164–01–P chartered, external advisory group
fees would be for FY 2019 based on the composed of scientists from the public
fully supported FTE hourly rates for FY and private sectors, will review and
2019 and estimates of the number of DEPARTMENT OF HEALTH AND provide advice on programmatic
hours it would take FDA to perform HUMAN SERVICES activities. This meeting is by webcast
relevant activities as outlined in the only and is open to the public.
National Institutes of Health Registration is requested for oral
Final Regulatory Impact Analysis for the
Third-Party Certification Regulation. comment and is required to access the
National Institute of Biomedical webcast. Information about the meeting
Table 4 provides an overview of the Imaging and Bioengineering; Notice of
estimated fees for other fee categories. and registration are available at http://
Closed Meeting ntp.niehs.nih.gov/go/165.
TABLE 4—ESTIMATED FEE RATES FOR Pursuant to section 10(d) of the DATES:
Meeting: October 9, 2018; 1:00—4:00
OTHER FEE CATEGORIES UNDER Federal Advisory Committee Act, as p.m. (EDT).
amended, notice is hereby given of a
THE FSMA THIRD-PARTY CERTIFI- Written Public Comment
meeting.
CATION PROGRAM The meetings will be closed to the Submissions: Deadline is October 1,
public in accordance with the 2018.
Estimated provisions set forth in sections Oral Comments: Deadline is October
fee rates 1, 2018.
Fee category for 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
FY 2019 as amended. The grant applications and Registration to view the webcast:
the discussions could disclose Deadline October 9, 2018.
Renewal application fee for rec- confidential trade secrets or commercial Registration to view the meeting via
ognized accreditation body ... $21,350 property such as patentable material, the webcast is required.
Renewal application fee for di- and personal information concerning ADDRESSES:
rectly accredited certification individuals associated with the grant Meeting Webpage: The preliminary
body ...................................... 28,999 applications, the disclosure of which agenda, registration, and other meeting
Annual fee for certification body would constitute a clearly unwarranted materials are at http://ntp.niehs.nih.gov/
directly accredited by FDA .... 21,056 go/165.
invasion of personal privacy.
Webcast: The meeting will be
V. How must the fee be paid? Name of Committee: National Institute of webcast; the URL will be provided to
Biomedical Imaging and Bioengineering
Special Emphasis Panel, NIBIB Team-based
those who register for viewing.
Accreditation bodies seeking initial FOR FURTHER INFORMATION CONTACT: Dr.
R25 Review (2019/01).
recognition must submit the application Date: September 24, 2018. Mary Wolfe, Designated Federal Official
fee with the application. Time: 10:00 a.m. to 5:00 p.m. for the BSC, Office of Liaison, Policy
amozie on DSK3GDR082PROD with NOTICES1
For recognized accreditation bodies Agenda: To review and evaluate grant and Review, Division of NTP, NIEHS,
and accredited certification bodies, an applications. P.O. Box 12233, K2–03, Research
invoice will be sent annually. Payment Place: National Institutes of Health, Triangle Park, NC 27709. Phone: 984–
National Institute of Biomedical Imaging and
must be made within 30 days of the Bioengineering, 6707 Democracy Blvd., Suite 287–3209, Fax: 301–451–5759, Email:
invoice date. Detailed payment 920, Bethesda, MD 20892 (Virtual Meeting). wolfe@niehs.nih.gov. Hand Deliver/
information will be included with the Contact Person: Ruixia Zhou, Ph.D., Courier address: 530 Davis Drive, Room
invoice when it is issued. Scientific Review Officer, National Institute K2130, Morrisville, NC 27560.
VerDate Sep<11>2014 17:25 Aug 29, 2018 Jkt 244001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\30AUN1.SGM 30AUN1](https://thefederalregister.org/doc/83_FR_44446/page/4.svg)
Document Created: 2018-08-30 01:21:37
Document Modified: 2018-08-30 01:21:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | This fee is effective October 1, 2018. | |
| Contact | Donald Prater, Office of Foods and Veterinary Medicine, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 3234, Silver Spring, MD 20993, 301-348-3007. | |
| FR Citation | 83 FR 44277 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR